Stocks
EWLNKEWLNK
HealthcareBiotechnology
A clinical-stage biotechnology company developing targeted therapies for rare genetic disorders. Its lead programs focus on enzyme replacement and gene therapy approaches for conditions with high unmet medical need. Investors track EWLNK for its pipeline milestones and potential partnerships with larger pharmaceutical firms.
Congressional Interest in EWLNK (EWLNK)
1 member of Congress has disclosed 1 trade in EWLNK (EWLNK), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading EWLNK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-08-06 | KENNY MARCHANT | buy | $15K-$50K |